Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
HIGH-COST PROTECTION AND PHARMACEUTICALS CONSUMPTION IN SWEDEN
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. (Pharmacoepidemiology & Pharmacoeconomy)
2022 (English)Independent thesis Advanced level (degree of Master (Two Years)), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

ABSTRACT 

BACKGROUND: Access to medicine is a basic human right and one of the fundamentals of an efficient healthcare system. Therefore, many countries have developed different models to ensure that their citizens have access to affordable and good quality medicines. According to the Swedish reimbursement model, all patients receive free medicines when passing a threshold of 2400 SEK (Year 2022) of co-payment. However, providing free access to medicines without co-payment while at the same time avoiding overuse is a challenge.  

AIM: The main aims of this study were to describe the proportion of patients reaching the threshold for no co-payment and to investigate if there is an increase in the amount of dispensed prescription only medications after reaching the threshold within the Swedish reimbursement model. 

METHOD: A retrospective cross-sectional registry-based study was conducted using data on all dispensed prescriptions in Sweden during the period 2012-2017. The proportion of patients reaching the threshold was described annually by age and sex. Volumes of drugs dispensed measured in DDD were assessed for all major ATC 2nd level groups three month before and three months after patients reached the threshold, respectively. 

RESULT: A total of 32,4 Million persons purchased prescription medicines during the period. One third of them (33%) reached the threshold and utilize the benefit of free cost. On average a 30% increase in volumes of dispensed medications were observed when comparing dispensing some therapeutic groups before and after the threshold was reached.

CONCLUSION: Access to quality assured medicines is a key factor in determining the overall quality and equity of a healthcare system. However, it is important to ensure the balance between cost, affordability, and rational use. This study showed that 33% of all patients reach the threshold for free medicines annually with no gender difference and indicated that some patients purchase more drugs after reaching the threshold. Further studies are needed to assess whether this is rational or not.

Place, publisher, year, edition, pages
2022. , p. 36
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:uu:diva-477700OAI: oai:DiVA.org:uu-477700DiVA, id: diva2:1672421
Subject / course
Pharmacy
Educational program
Master Programme in Drug Management
Supervisors
Examiners
Available from: 2022-06-28 Created: 2022-06-19 Last updated: 2025-02-24Bibliographically approved

Open Access in DiVA

No full text in DiVA

By organisation
Department of Pharmacy
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 532 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf